4.8 Article

XAB2 promotes Ku eviction from single-ended DNA double-strand breaks independently of the ATM kinase

期刊

NUCLEIC ACIDS RESEARCH
卷 49, 期 17, 页码 9906-9925

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkab785

关键词

-

资金

  1. Televie/Fonds National de la Recherche (F.R.S.FNRS)/Fonds National de la Recherche du Luxembourg (FNR) [7.4503.11, 7.4633.16]
  2. Doctoral School for Systems and Molecular Biomedicine, University of Luxembourg
  3. FNR (PRIDE grant)
  4. Ligue Nationale Contre le Cancer
  5. Canadian Institutes of Health Research Foundation [FDN388879]

向作者/读者索取更多资源

In this study, XAB2 was identified as a factor required for resistance to seDSBs induced by the chemotherapeutic drug temozolomide, and it prevents Ku retention and abortive HR at seDSBs induced by temozolomide and camptothecin through a pathway operating parallel to the ATM-CtIP-MRE11 axis. XAB2 depletion results in unproductive RAD51-ssDNA associations, leading to increased NHEJ engagement and genetic instability in S/G2.
Replication-associated single-ended DNA double-strand breaks (seDSBs) are repaired predominantly through RAD51-mediated homologous recombination (HR). Removal of the non-homologous end-joining (NHEJ) factor Ku from resected seDSB ends is crucial for HR. The coordinated actions of MRE11-CtIP nuclease activities orchestrated by ATM define one pathway for Ku eviction. Here, we identify the pre-mRNA splicing protein XAB2 as a factor required for resistance to seDSBs induced by the chemotherapeutic alkylator temozolomide. Moreover, we show that XAB2 prevents Ku retention and abortive HR at seDSBs induced by temozolomide and camptothecin, via a pathway that operates in parallel to the ATM-CtIP-MRE11 axis. Although XAB2 depletion preserved RAD51 focus formation, the resulting RAD51-ssDNA associations were unproductive, leading to increased NHEJ engagement in S/G2 and genetic instability. Overexpression of RAD51 or RAD52 rescued the XAB2 defects and XAB2 loss was synthetically lethal with RAD52 inhibition, providing potential perspectives in cancer therapy. [GRAPHICS] .

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据